Difficulty: Medium
Average Score: 86%
Practice
A 64-year-old man with Parkinson disease complained of periods of complete immobility, followed by involuntary movements. The patient's current medications included levodopa/carbidopa. To reduce these rapid fluctuations, the neurologist reduced the daily dose of levodopa/carbidopa and added a drug. Which of the following drugs was most likely prescribed?
Correct answer
D
Rationale
The correct answer is D) Pramipexole. In this scenario, the patient is experiencing motor fluctuations and dyskinesias, which are common complications of long-term levodopa therapy in Parkinson's disease. Pramipexole, a dopamine agonist, is often prescribed in conjunction with levodopa to help smooth out these fluctuations by providing a more continuous stimulation of dopamine receptors.
A) Amantadine is another drug used in Parkinson's disease, primarily for its antiviral properties, but it is not typically used to address motor fluctuations like those described in the case.
B) Benztropine is an anticholinergic agent used to treat extrapyramidal symptoms caused by antipsychotic medications but is not indicated for the management of motor fluctuations in Parkinson's disease.
C) Haloperidol is an antipsychotic medication that can worsen motor symptoms in Parkinson's disease patients and is not recommended in this case.
Educationally, understanding the rationale behind choosing Pramipexole in this situation highlights the importance of combination therapy and individualized treatment plans in managing complex conditions like Parkinson's disease. It underscores the need for healthcare providers to consider the mechanism of action of each drug, the specific symptoms being addressed, and potential drug interactions when making treatment decisions for patients.
A) Amantadine is another drug used in Parkinson's disease, primarily for its antiviral properties, but it is not typically used to address motor fluctuations like those described in the case.
B) Benztropine is an anticholinergic agent used to treat extrapyramidal symptoms caused by antipsychotic medications but is not indicated for the management of motor fluctuations in Parkinson's disease.
C) Haloperidol is an antipsychotic medication that can worsen motor symptoms in Parkinson's disease patients and is not recommended in this case.
Educationally, understanding the rationale behind choosing Pramipexole in this situation highlights the importance of combination therapy and individualized treatment plans in managing complex conditions like Parkinson's disease. It underscores the need for healthcare providers to consider the mechanism of action of each drug, the specific symptoms being addressed, and potential drug interactions when making treatment decisions for patients.